Why Perrigo Stock Tanked on Tuesday
Drug company Perrigo (NYSE: PRGO) experienced quite a headache on Tuesday after it released its third-quarter report before the bell. For the period, Perrigo booked total sales of $1.1 billion, which was nearly 6% higher on a year-over-year basis. Perrigo has a wide range of products in its portfolio.